Skip to main content

Table 1 Oxidant status and iron incorporation in VLBW Infants during treatment with EPO plus iron

From: Iron absorption and oxidant stress during erythropoietin therapy in very low birth weight premature infants: a cohort study

 

Baseline

Week 2

Week 4

PLASMA TRAP (umol/L

492 ± 3451

510 ± 316

438 ± 293

PLASMA MDA (umol/L)

0.35 ± 0.47

0.33 ± 0.24

0.42 ± 0.48

URINE F2 -Isoprostanes (ng/mL)

19 ± 14

29 ± 30

30 ± 19

RBC SOD (U/mL)

3.1 ± 2

4.0 ± 2.3

3.8 ± 2.1

RBC CAT (U/mL)

62 ± 19

68 ± 25

75 ± 25

INCORP (%)

______

8.5 ± 4.2

7.8 ± 4.4

  1. 1means ± S.D.
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us